NCT00293579View on ClinicalTrials.gov

Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

November 30, 2008

Conditions
Head and Neck Cancer
Interventions
DRUG

Pemetrexed

500 mg/m2 IV every 3 weeks for 6 cycles

Trial Locations (1)

43210

Ohio State University, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT00293579 - Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer | Biotech Hunter | Biotech Hunter